Wireless heart failure sensor technology gets $37.9m
This article was originally published in Clinica
Executive Summary
Wireless sensing specialist CardioMEMS has raised $37.9m in additional financing from its existing shareholders. The funds will enable the company to complete the US pivotal trial of its wireless heart failure pressure measurement system. The Atlanta, Georgia firm said it completed enrolment of its 550-patient CHAMPION clinical trial in 2009, and expects to have the results in the second half of this year. CardioMEMS' wireless heart failure sensor is a miniature device that is implanted into the patient’s pulmonary artery using a catheter-based procedure. Following the procedure, patients can take measurements of their pulmonary artery pressure wirelessly from home, using a proprietary electronic monitoring system. The data is immediately transmitted to a database and is available for review by the doctor on the CardioMEMS website.